
Investment Rating - The report assigns a "Buy" rating to the company with a target price of HKD 58.68, indicating a potential upside of 42.3% from the current price of HKD 41.25 [1][2][7]. Core Insights - The company's 2023 performance exceeded expectations, with a net profit margin reaching a historical high of 28.3%. Sales and net profit grew by 28.4% and 42.2% year-on-year, respectively, totaling RMB 42.67 billion and RMB 12.08 billion [1][5]. - The beverage segment's revenue contribution surpassed that of packaged water for the first time, with tea beverages showing exceptional growth of over 100% in the second half of 2023 [1][5]. - The company anticipates double-digit revenue growth for 2024, despite some challenges in e-commerce channels, and expects gross margins to remain stable in the first half of 2024 [1][5]. Financial Overview - 2023 Financial Performance: - Revenue: RMB 42.67 billion, up 28.4% YoY - Net Profit: RMB 12.08 billion, up 42.2% YoY - Gross Margin: 59.5%, an increase of 2.1 percentage points YoY - Net Profit Margin: 28.3%, an increase of 2.8 percentage points YoY [1][5][8]. - 2024 Projections: - Expected Revenue: RMB 49.36 billion, with a growth rate of 15.7% - Expected Net Profit: RMB 12.99 billion, with a growth rate of 7.6% - Projected Gross Margin: 59.6% [2][8]. Segment Performance - Beverage Segments: - Packaged Water: Contributed 48% of sales, with a YoY growth of 11% - Tea Beverages: Contributed 30% of sales, with a remarkable YoY growth of 83% - Functional Beverages: Contributed 11% of sales, with a YoY growth of 28% - Juice: Contributed 8% of sales, with a YoY growth of 23% [1][5][6]. Market Position - The company has established a strong market position with a significant increase in its tea beverage offerings, driven by consumer health trends and new product launches [1][5]. - The stock has shown resilience, with a 52-week high of HKD 46.30 and a low of HKD 38.50, reflecting a stable market presence [4][7].